Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/180 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME12960496
PMID: | 12960496
LR: | 20051116
CED: | 20030908
DCO: | 20031216
Autoren: | Reginster JY; Bruyere O; Lecart MP; Henrotin Y
Titel: | Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis.
Quelle: | Current opinion in rheumatology; VOL: 15 (5); p. 651-5 /200309/
PM: | Print
SU: | IM
Sprache: | English
CY: | United States
JID: | 9000851
ISSN: | 1040-8711
CO: | CORHES
Institution: | Bone and Cartilage Metabolism Research Unit, University of Liège, Belgium. jyreginster@ulg.ac.be
DT: | Journal Article; Review
RN: | 31
Schlagwörter
CT: | ANTIRHEUMATIC AGENTS/*administration & dosage; CHONDROITIN SULFATES/*administration & dosage; DISEASE PROGRESSION; GLUCOSAMINE/*administration & dosage; HUMANS; OSTEOARTHRITIS/physiopathology; OSTEOARTHRITIS/prevention & control; OSTEOARTHRITIS/*rehabilitation
CTG: | ANTIRHEUMATIKA/*Verabreichung & Dosierung; CHONDROITINSULFATE/*Verabreichung & Dosierung; KRANKHEITSPROGRESSION; GLUCOSAMIN/*Verabreichung & Dosierung; MENSCH; OSTEOARTHROSE/Pathophysiologie; OSTEOARTHROSE/Verhütung & Bekämpfung; OSTEOARTHROSE/*Rehabilitation
TE: | Antirheumatic Agents; Glucosamine/3416-24-8; Chondroitin Sulfates/9007-28-7
CR: | 3416-24-8; 9007-28-7
AB: | PURPOSE OF REVIEW: Several entities have been investigated carefully for the symptomatic and structural management of osteoarthritis. This review reports recent findings suggesting that such compounds may delay the structural progression of osteoarthritis. RECENT FINDINGS: The most compelling evidence of a potential for inhibiting the structural progression of osteoarthritis has been obtained with glucosamine sulfate, whereas preliminary results obtained in patients with osteoarthritis of the hands also suggest that chondroitin sulfate could be used in the same indication. At any rate, these two compounds have clearly demonstrated a symptomatic action, mainly in osteoarthritis of the lower limbs. Patients with the less severe radiographic osteoarthritis will experience, in the long run, the most dramatic disease progression in terms of joint space narrowing. Such patients may be particularly responsive to structure-modifying drugs. SUMMARY: Glucosamine sulfate has demonstrated its ability to reduce the progression of osteoarthritis in the lower limbs. The preliminary results obtained in the hands suggest that chondroitin sulfate could also be of interest in this indication. An important issue is that all the conclusive studies with such chemical entities resulted from the use of prescription medicines, not over-the-counter pills or food supplements.

» Volltext »
» Fenster schließen »